Abstract
OBJECTIVE: To investigate the impact of two common polymorphisms in the human β2-adrenoceptor gene (Gly16Arg and Gln27Glu substitutions) on obesity and anthropometric measurements as well as blood variables in a large sample of a French population.
DESIGN AND SUBJECTS: Within the framework of the WHO-MONICA project, a population study composed of 1195 subjects aged 35–64 y was randomly sampled from the electoral rolls of the Urban Community of Lille, in northern France. Subjects without any medical treatment (for hypercholesterolaemia, hypertension or diabetes mellitus) susceptible to interfere with body weight and biological variables were selected (n=836, 419 men/417 women, age=49.5±8.1 y, body mass index (BMI)=25.7±4.4 kg/m2). Subjects with a body mass index ≥30 kg/m2 were considered as obese (n=119, age=49.5±8.2 y, BMI=33.9±3.3 kg/m2 range 30–44).
MEASUREMENTS: Genotyping was carried out with allele-specific oligonucleotides hybridization. Association between genotypes and various obesity markers (body weight, body mass index, waist and waist-to-hip ratio), lipid, glucose and insulin variables were studied.
RESULTS: The Gly16Arg and Gln27Glu polymorphisms were in complete linkage disequilibrium. Gln27Gln subjects had an increased risk of obesity (odds ratio (OR)=1.77, 95% CI 1.19–2.62, P=0.005). This effect was mainly detected in men (OR=2.40, 95% CI 1.34–4.27, P=0.003). Men bearing the Gln27Gln genotype had higher body weight, BMI, waist and hip circumferences and waist-to-hip ratio than others. Moreover, if Gln27Gln men carried in addition the Arg16 allele, the increase in body weight, BMI and waist-to-hip ratio was more important.
CONCLUSION: Our results suggest that genetic variability of the β2-adrenoceptor gene is implicated in body weight regulation and in the onset of obesity in French men.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arner P . Control of lipolysis and its relevance to development of obesity in man Diabetes Metab Rev 1988 4: 507–515.
Lafontan M, Barbe P, Galitzky J, Tavernier G, Langin D, Carpene C, Bousquet-Melou A, Berlan M . Adrenergic regulation of adipocyte metabolism Hum Reprod 1997 12 (Suppl 1): 6–20.
Reihsaus E, Innis M, MacIntyre N, Liggett SB . Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects Am J Respir Cell Mol Biol 1993 8:: 334–339.
Turki J, Pak J, Green SA, Martin RJ, Liggett SB . Genetic polymorphisms of the β2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype J Clin Invest 1995 95: 1635–1641.
Liggett SB . Genetics of β2-adrenergic receptor variants in asthma Clin Exp Allergy 1995 25 (Suppl 2): 89–94.
Hopes E, McDougall C, Christie G, Dewar J, Wheatley A, Hall IP, Helms PJ . Association of glutamine 27 polymorphism of β2 adrenoceptor with reported childhood asthma: population based study Br Med J 1998 316: 664.
Timmermann B, Mo R, Luft FC, Gerdts E, Busjahn A, Omvik P, Li GH, Schuster H, Wienker TF, Hoehe MR, Lund-Johansen P . β2-adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: the Bergen Blood Pressure Study Kidney Int 1998 53: 1455–1460.
Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, Arner P . Human β2-adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte β2-adrenoceptor function J Clin Invest 1997 100: 3005–3013.
Echwald SM, Sorensen TI, Tybjaerg-Hansen A, Andersen T, Pedersen O . Gln27Glu variant of the human β2-adrenoreceptor gene is not associated with early-onset obesity in Danish men Diabetes 1998 47: 1657–1658.
Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K . Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus Diabetologia 1999 42: 98–101.
Hellstrom L, Large V, Reynisdottir S, Wahrenberg H, Arner P . The different effects of a Gln27Glu β2-adrenoceptor gene polymorphism on obesity in males and in females J Intern Med 1999 245: 253–259.
Mori Y, Kim-Motoyama H, Ito Y, Katakura T, Yasuda K, Ishiyama-Shigemoto S, Yamada K, Akanuma Y, Ohashi Y, Kimura S, Yazaki Y, Kadowaki T . The Gln27Glu β2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men Biochem Biophys Res Commun 1999 258: 138–140.
Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. The World Health Organization MONICA Project Int J Epidemiol 1994 23: 505–516.
Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J, Amouyel P . A genetic polymorphism of the peroxisome proliferator-activated receptor γ gene influences plasma leptin levels in obese humans Hum Mol Genet 1998 7: 435–440.
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16: 1215.
Emorine LJ, Marullo S, Delavier-Klutchko C, Kaveri SV, Durieu-Trautmann O, Strosberg AD . Structure of the gene for human β2-adrenergic receptor: expression and promoter characterization Proc Natl Acad Sci USA 1987 84: 6995–6999.
Thompson EA, Deeb S, Walker D, Motulsky AG . The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes Am J Hum Genet 1988 42: 113–124.
Hill WG . Tests for association of gene frequencies at several loci in random mating diploid populations Biometrics 1975 31: 881–888.
Jensen MD . Lipolysis: contribution from regional fat A Rev Nutr 1997 17: 127–139.
Engfeldt P, Arner P . Lipolysis in human adipocytes, effects of cell size, age and of regional differences Horm Metab Res Suppl 1988 19 (26-9): 26–29.
Van Harmelen V, Lonnqvist F, Thorne A, Wennlund A, Large V, Reynisdottir S, Arner P . Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects Int J Obes Relat Metab Disord 1997 21: 972–979.
Leibel RL, Hirsch J . Site- and sex-related differences in adrenoreceptor status of human adipose tissue J Clin Endocrinol Metab 1987 64: 1205–1210.
Wahrenberg H, Lonnqvist F, Arner P . Mechanisms underlying regional differences in lipolysis in human adipose tissue J Clin Invest 1989 84: 458–467.
Meirhaeghe A, Helbecque N, Cottel D, Amouyel P . β2-adrenoceptor gene polymorphism, body weight, and physical activity Lancet 1999 353: 896.
Sakane N, Yoshida T, Umekawa T, Kogure A, Kondo M . β2-adrenoreceptor gene polymorphism and obesity Lancet 1999 353: 1976.
Green SA, Turki J, Innis M, Liggett SB . Amino-terminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties Biochemistry 1994 33: 9414–9419.
Aubert JP, Helbecque N, Loucheux-Lefebvre MH . Circular dichroism studies of synthetic Asn-X-Ser/Thr-containing peptides: Structure-glycosylation relationship Arch Biochem Biophys 1981 208: 20–29.
McGraw DW, Forbes SL, Kramer LA, Liggett SB . Polymorphisms of the 5′ leader cistron of the human β2-adrenergic receptor regulate receptor expression J Clin Invest 1998 102: 1927–1932.
Kobilka BK, Frielle T, Dohlman HG, Bolanowski MA, Dixon RA, Keller P, Caron MG, Lefkowitz RJ . Delineation of the intronless nature of the genes for the human and hamster β2-adrenergic receptor and their putative promoter regions J Biol Chem 1987 262: 7321–7327.
Acknowledgements
We would like to thank Selaiman Rahimi, Valérie Codron and Xavier Hermant for technical assistance. AM was supported by a grant from the Fondation pour la Recherche Médicale. The WHO-MONICA population study developed in the North of France was supported by grants from the Conseil Régional du Nord-Pas de Calais, the Fondation pour la Recherche Médicale, ONIVINS, the Parke–Davis Laboratory, the Mutuelle Générale de l'Education Nationale (MGEN), the Réseau National de Santé Publique, the Direction Générale de La Santé, the Institut National de la Santé Et de la Recherche Médicale (INSERM), the Institut Pasteur de Lille and the Unité d'Evaluation du Centre Hospitalier et Universitaire de Lille.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meirhaeghe, A., Helbecque, N., Cottel, D. et al. Impact of polymorphisms of the human β2-adrenoceptor gene on obesity in a French population. Int J Obes 24, 382–387 (2000). https://doi.org/10.1038/sj.ijo.0801168
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801168
Keywords
This article is cited by
-
The influence of six polymorphisms of uncoupling protein 3 (UCP3) gene and childhood obesity: a case–control study
BMC Pediatrics (2023)
-
Association of Common Polymorphisms in the Fractalkine Receptor (CX3CR1) With Obesity
Obesity (2011)
-
ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics
The Pharmacogenomics Journal (2010)
-
Association of Codon 16 and Codon 27 β2‐Adrenergic Receptor Gene Polymorphisms with Obesity: A Meta‐analysis
Obesity (2008)
-
Performance of a neuro-fuzzy model in predicting weight changes of chronic schizophrenic patients exposed to antipsychotics
Molecular Psychiatry (2008)